Skip to main content
Canna~Fangled Abstracts

The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans

By February 22, 2022February 23rd, 2022No Comments

Review
. 2022 Feb 22;38(1):5.

doi: 10.1186/s42826-022-00116-5.

Ricardo Lacava Bailone 1 2, Hirla Costa Silva Fukushima 3, Luis Kluwe de Aguiar 4, Ricardo Carneiro Borra 5
Affiliations 

Abstract

Zebrafish is considered an unprecedented animal model in drug discovery. A review of the literature presents highlights and elucidates the biological effects of chemical components found in Cannabis sativa. Particular attention is paid to endocannabinoid system (eCB) and its main receptors (CB1 and CB2). The zebrafish model is a promising one for the study of cannabinoids because of the many similarities to the human system. Despite the recent advances on the eCB system, there is still the need to elucidate some of the interactions and, thus, the zebrafish model can be used for that purpose as it respects the 3Rs concept and reduced time and costs. In view of the relevance of cannabinoids in the treatment and prevention of diseases, as well as the importance of the zebrafish animal model in elucidating the biological effects of new drugs, the aim of this study was to bring to light information on the use of the zebrafish animal model in testing C. sativa-based medicines.

Keywords: 3R, Animal model research, CB1, CB2, Cannabidiol, ∆9-tetrahydrocannabinol

References

    1. Falcão MAP, de Souza LS, Dolabella SS, Guimarães AG, Walker CIB. Zebrafish as an alternative method for determining the embryo toxicity of plant products: a systematic review. Environ Sci Pollut Res. 2018;25(35):35015–26.
    1. Jaques SC, Kingsbury A, Henshcke P, Chomchai C, Clews S, Falconer J, et al. Cannabis, the pregnant woman and her child: weeding out the myths. J Perinatol. 2014;34(6):417–24. – PubMed
    1. Hill MB, Gorzalka BB. Pharmacological enhancement of cannabinoid CB1 receptor activity. Eur Neuropsychopharmacol. 2005;15:593–9. – PubMed
    1. Berger AA, Keefe J, Winnick A, Gilbert E, Eskander JP, Yazdi C, et al. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Pract Res Clin Anaesthesiol. 2020. https://doi.org/10.1016/j.bpa.2020.08.010 . – DOI
    1. Cooray R, Gupta V, Suphioglu C. Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson’s and Alzheimer’s diseases: a review. Mol Neurobiol. 2020;57(11):4878–90. – PubMed – PMC

Publication types

Leave a Reply